AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

DALTEPARIN SODIUM

10 registrations across 2 African markets— 4 active

Markets with DALTEPARIN SODIUM

🇿🇦South Africa
6 registrations
0 active
🇬🇭Ghana
4 registrations
4 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
FRAGMIN (DALTEPARIN SODIUM) 2500IU SOLUTION FOR INJECTION🇬🇭Ghana—activeOct 2030
FRAGMIN (DALTEPARIN SODIUM) 2500IU SOLUTION FOR INJECTION🇬🇭Ghana—activeOct 2030
FRAGMIN🇬🇭Ghana—activeJun 2029
FRAGMIN🇬🇭Ghana—activeJun 2029
FRAGMIN 2 500 IU / ml🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedAug 2022
FRAGMIN 2 500 IU🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedAug 2022
FRAGMIN 5 000 iu🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedAug 2022
FRAGMIN 12 500 IU/0,5 ml🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedAug 2022
FRAGMIN 15 000 IU/0,6 ml🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedAug 2022
FRAGMIN 18 000 IU/0,72 ml🇿🇦South AfricaPfizer Laboratories (Pty) LtdsuspendedAug 2022

DALTEPARIN SODIUM in Africa — Regulatory Overview

DALTEPARIN SODIUM is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 4 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.